Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Antisense compound targeting cholesterol reported

Jan. 29, 1997

MK-677 enhances GH activity in the elderly

Jan. 29, 1997

TKT product advances toward the clinic

Jan. 29, 1997

Japanese researchers isolate novel ACAT inhibitor

Jan. 29, 1997

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Jan. 29, 1997

Hypocholesterolemic activity of raloxifene established in rats

Jan. 28, 1997

GRF analogues developed for growth hormone deficiencies

Jan. 28, 1997

Nisshin Flour Milling claims antidiabetic compounds

Jan. 28, 1997

Therapeutically active PTH derivatives reported by Takeda

Jan. 27, 1997

Phase I trials begin for Fabry's disease

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...